Does testosterone cause constant hunger in FTM patients?
Quick answer
Testosterone therapy in transmasculine patients produces documented increases in lean muscle mass and basal metabolic rate, both of which can drive genuine increases in caloric demand. However, the degree of appetite change varies significantly by dose, administration route, individual androgen receptor sensitivity, and psychological factors including relief of dysphoria-associated restrictive eating. Clinicians should proactively discuss appetite and nutritional changes with patients initiating gender-affirming hormone therapy rather than leaving it to social media communities to set expectations.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What's this video probably claiming?
Based on the caption and hashtag context, @zelahglasson is describing persistent, year-long increased hunger since starting testosterone therapy as part of FTM (female-to-male) gender-affirming hormone therapy. This is one of the most commonly reported subjective experiences in transmasculine TRT communities on TikTok, and it's not fabricated. The claim being floated, implicitly or explicitly, is that testosterone itself is the driver of this increased appetite, sometimes framed as unavoidable, sometimes framed as a feature rather than a bug. Videos in this category often tie hunger to muscle building, metabolic shifts, or "eating like a man now," with variable accuracy. Whether the creator is celebrating this, complaining about it, or just documenting it matters a lot for how we evaluate the claim, and we don't have the transcript yet. What we can do is assess whether the underlying biology holds up.
What does the science actually show?
Testosterone does influence appetite regulation, but the mechanism is more complicated than most TikTok content suggests. Research by Mauvais-Jarvis (2011, Diabetes) and later work by Afonso et al. (2020, Frontiers in Endocrinology) identified that androgens interact with hypothalamic appetite circuits, particularly influencing ghrelin and leptin sensitivity. In transmasculine individuals on testosterone, lean muscle mass increases significantly, often 3-5 kg within the first year at standard doses, which raises basal metabolic rate and creates genuine caloric demand. A 2019 study by Klaver et al. in the Journal of Clinical Endocrinology and Metabolism tracked body composition in 179 transgender men over 12 months and confirmed significant increases in fat-free mass alongside decreased fat mass. More muscle requires more fuel. That part checks out. However, the subjective experience of hunger being constant or overwhelming is not universally documented in clinical literature, and dose, administration route, and individual androgen receptor sensitivity all modulate outcomes considerably.
Where does the social media noise diverge from clinical reality?
The divergence happens in a few predictable places. First, TikTok content in the FTM-HRT space tends to universalize individual experiences. One person's year of constant hunger becomes a community expectation, which shapes how new patients interpret their own symptoms. That's not science, that's social priming. Second, the appetite changes described online rarely account for psychological factors. Gender dysphoria relief following hormone initiation is associated with improved mood, reduced anxiety, and reduced restrictive eating behaviors in some patients, as documented by Diemer et al. (2015, LGBT Health). What looks like testosterone-driven hunger may partly be a normalization of eating. Third, some creators conflate FTM HRT with performance-enhancing TRT protocols, which use substantially higher testosterone levels and are a different clinical context entirely. Standard gender-affirming testosterone therapy targets physiological male ranges, typically 400-700 ng/dL, not supraphysiological levels used in bodybuilding contexts. Conflating these two populations misleads both audiences.
What should you actually know?
If you're on testosterone therapy and experiencing increased hunger, the experience is real and has biological plausibility behind it. But a few things are worth knowing before you run with the "testosterone makes you starving" narrative. Appetite changes should be monitored in context of overall metabolic health. Uncontrolled caloric surplus, even driven by legitimate increased metabolic demand, can shift body composition in ways patients don't intend, particularly increasing visceral adipose tissue if protein intake and resistance training don't accompany the caloric increase. Dhindsa et al. (2016, Diabetes Care) documented that testosterone therapy affects insulin sensitivity, which can influence hunger signaling independently of muscle mass changes. Anyone experiencing dramatic or distressing appetite changes should discuss it with their prescribing clinician, not just validate it against a TikTok comment section. This is especially true for patients with any history of disordered eating, where hormone-driven appetite shifts require careful clinical support, not just community reassurance.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Does testosterone cause constant hunger in FTM patients?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Understanding weight gain at menopause
Background source for body-composition and weight-change discussions around menopause.
PubMed
Management of obesity in menopause
Current source for menopause-specific obesity management framing.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Does testosterone cause constant hunger in FTM patients? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Testosterone therapy in transmasculine patients produces documented increases in lean muscle mass and basal metabolic rate, both of which can drive genuine increases in caloric demand.
FormBlends verdict
Testosterone therapy in transmasculine patients produces documented increases in lean muscle mass and basal metabolic rate, both of which can drive genuine increases in caloric demand. However, the degree of appetite change varies significantly by dose, administration route, individual androgen receptor sensitivity, and psychological factors including relief of dysphoria-associated restrictive eating. Clinicians should proactively discuss appetite and nutritional changes with patients initiating gender-affirming hormone therapy rather than leaving it to social media communities to set expectations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Testosterone therapy in transmasculine patients produces documented increases in lean muscle mass and basal metabolic rate, both of which can drive genuine increases in caloric demand. However, the degree of appetite change varies significantly by dose, administration route, individual androgen receptor sensitivity, and psychological factors including relief of dysphoria-associated restrictive eating. Clinicians should proactively discuss appetite and nutritional changes with patients initiating gender-affirming hormone therapy rather than leaving it to social media communities to set expectations.
- Testosterone therapy increases lean muscle mass by approximately 3-5 kg in the first 12 months, raising basal metabolic rate and creating real caloric demand.
- Standard gender-affirming testosterone therapy targets physiological male testosterone ranges of roughly 400-700 ng/dL, not the supraphysiological levels used in performance contexts.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Testosterone therapy increases lean muscle mass by approximately 3-5 kg in the first 12 months, raising basal metabolic rate and creating real caloric demand.
- Standard gender-affirming testosterone therapy targets physiological male testosterone ranges of roughly 400-700 ng/dL, not the supraphysiological levels used in performance contexts.
- Appetite changes on testosterone are real but not universal. Dose, administration route, and individual androgen receptor sensitivity all affect outcomes.
- Some reported hunger increases in FTM patients may reflect normalization of eating following dysphoria relief, not testosterone pharmacology alone.
- Testosterone affects insulin sensitivity, which can independently influence hunger signaling beyond just muscle mass changes.
- Patients with a history of disordered eating starting hormone therapy should receive dedicated nutritional support, not just community validation from social media.
- Individual TikTok experiences should not be treated as clinical norms. Community expectation-setting about hormone effects can distort how new patients interpret their own symptoms.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Zelah Glasson · TikTok creator
216.7K views on this video
I have been hungry this whole year #transgender #ftm #testosterone #trt #ftmhrt
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Zelah Glasson, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.